These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8819803)

  • 41. Prevention of postoperative recurrence in Crohn's disease.
    D'Haens G
    Curr Gastroenterol Rep; 1999 Dec; 1(6):476-81. PubMed ID: 10980989
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quality-of-life results of double-blind, placebo-controlled trial of mesalamine in patients with Crohn's disease.
    Singleton JW; Hanauer S; Robinson M
    Dig Dis Sci; 1995 May; 40(5):931-5. PubMed ID: 7729281
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of postoperative Crohn's disease.
    Froehlich F; Juillerat P; Felley C; Mottet C; Vader JP; Burnand B; Michetti P; Gonvers JJ
    Digestion; 2005; 71(1):49-53. PubMed ID: 15711050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Maintenance strategies in Crohn's disease.
    Sachar DB
    Hosp Pract (1995); 1996 Jan; 31(1):99-106. PubMed ID: 8595995
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aminosalicylate as prophylaxis for Crohn's disease.
    Qasim A; Seery J; O'Morain CA
    Gut; 2001 Dec; 49(6):873. PubMed ID: 11758501
    [No Abstract]   [Full Text] [Related]  

  • 46. Is Asacol as effective as sulphasalazine in maintaining remission of Crohn's disease and ulcerative colitis?
    Nakshabendi IM; Duncan A; Russell RI
    Postgrad Med J; 1992 Mar; 68(797):189-91. PubMed ID: 1350343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current treatment for prevention of relapse and recurrence in Crohn's disease.
    Prantera C; Scribano ML
    Ital J Gastroenterol Hepatol; 1999; 31(6):515-8. PubMed ID: 10575572
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 5-aminosalicylic acid in the prevention of relapses of Crohn's disease in remission: a long-term study.
    Bresci G; Petrucci A; Banti S
    Int J Clin Pharmacol Res; 1991; 11(4):200-2. PubMed ID: 1813439
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].
    Nos P; Hinojosa J; Aguilera V; Molés JR; Pastor M; Ponce J; Berenguer J
    Gastroenterol Hepatol; 2000 Oct; 23(8):374-8. PubMed ID: 11227650
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence.
    Regueiro M; Kip KE; Baidoo L; Swoger JM; Schraut W
    Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1494-502.e1. PubMed ID: 24440221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medical management of postoperative recurrence in Crohn's disease.
    Van Assche G; Rutgeerts P
    Gastroenterol Clin North Am; 2004 Jun; 33(2):347-60, x. PubMed ID: 15177543
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preventing postoperative recurrence of Crohn's disease.
    Borley NR; Mortensen NJ; Jewell DP
    Br J Surg; 1997 Nov; 84(11):1493-502. PubMed ID: 9393267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conventional treatment of Crohn's disease: objectives and outcomes.
    Rutgeerts PJ
    Inflamm Bowel Dis; 2001 May; 7 Suppl 1():S2-8. PubMed ID: 11380039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Crohn disease: prevention and drug therapy].
    Gross V; Andus T; Schölmerich J
    Chirurg; 1995 Aug; 66(8):757-63. PubMed ID: 7587538
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Maintenance of symptomatic remission in patients with Crohn's disease.
    Stark ME; Tremaine WJ
    Mayo Clin Proc; 1993 Dec; 68(12):1183-90. PubMed ID: 7902474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention and treatment of postoperative Crohn's disease recurrence with anti-TNF therapy: a meta-analysis of controlled trials.
    Carla-Moreau A; Paul S; Roblin X; Genin C; Peyrin-Biroulet L
    Dig Liver Dis; 2015 Mar; 47(3):191-6. PubMed ID: 25488057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention of post-operative recurrence of Crohn's disease requires adequate mucosal concentration of mesalazine. Gruppo Italiano per lo Studio del Colon e del Retto.
    Frieri G; Pimpo MT; Andreoli A; Annese V; Comberlato M; Corrao G; Palumbo G; Sturniolo GC; Tonelli F; Caprilli R
    Aliment Pharmacol Ther; 1999 May; 13(5):577-82. PubMed ID: 10233180
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coated oral 5-aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease. International Mesalazine Study Group.
    Aliment Pharmacol Ther; 1990 Feb; 4(1):55-64. PubMed ID: 2104074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease.
    Fedorak RN; Feagan BG; Hotte N; Leddin D; Dieleman LA; Petrunia DM; Enns R; Bitton A; Chiba N; Paré P; Rostom A; Marshall J; Depew W; Bernstein CN; Panaccione R; Aumais G; Steinhart AH; Cockeram A; Bailey RJ; Gionchetti P; Wong C; Madsen K
    Clin Gastroenterol Hepatol; 2015 May; 13(5):928-35.e2. PubMed ID: 25460016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn's Disease.
    Fortinsky KJ; Kevans D; Qiang J; Xu W; Bellolio F; Steinhart H; Milgrom R; Greenberg G; Cohen Z; Macrae H; Stempak J; McLeod R; Silverberg MS
    Dig Dis Sci; 2017 Jan; 62(1):188-196. PubMed ID: 27778204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.